Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C61317> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- NCIT_C61317 IAO_0000115 "A formulation of the citrate salt of the antineoplastic anthracycline antibiotic doxorubicin, encapsulated within liposomes, with antitumor activity. Doxorubicin intercalates into DNA and interacts with topoisomerase II, thereby inhibiting DNA replication and RNA synthesis. This agent also interacts with cell membrane lipids causing lipid peroxidation. Liposomal delivery of doxorubicin improves drug penetration into tumors and decreases drug clearance, thereby increasing the duration of therapeutic drug effects while lowering the toxicity profile." @default.
- NCIT_C61317 NCIT_A32 NCIT_C1909 @default.
- NCIT_C61317 NCIT_A7 NCIT_C18434 @default.
- NCIT_C61317 NCIT_NHC0 "C61317" @default.
- NCIT_C61317 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C61317 NCIT_P107 "Liposome-Encapsulated Doxorubicin Citrate" @default.
- NCIT_C61317 NCIT_P108 "Liposome-Encapsulated Doxorubicin Citrate" @default.
- NCIT_C61317 NCIT_P207 "C1512062" @default.
- NCIT_C61317 NCIT_P210 "111266-55-8" @default.
- NCIT_C61317 NCIT_P319 "AJQ2ZNG2WL" @default.
- NCIT_C61317 NCIT_P322 "CTRP" @default.
- NCIT_C61317 NCIT_P322 "FDA" @default.
- NCIT_C61317 NCIT_P322 "GDC" @default.
- NCIT_C61317 NCIT_P325 "A form of the anticancer drug doxorubicin citrate that is contained inside very tiny, fat-like particles. It is being studied in the treatment of breast cancer that has spread and in the treatment of other types of cancer. Doxorubicin citrate damages DNA and may kill cancer cells. Liposomal-encapsulated doxorubicin citrate may have fewer side effects and may work better than doxorubicin citrate." @default.
- NCIT_C61317 NCIT_P329 "481301" @default.
- NCIT_C61317 NCIT_P330 "481301" @default.
- NCIT_C61317 NCIT_P366 "Liposome-Encapsulated_Doxorubicin_Citrate" @default.
- NCIT_C61317 NCIT_P375 "Liposome-Encapsulated Doxorubicin Citrate" @default.
- NCIT_C61317 NCIT_P399 "481301" @default.
- NCIT_C61317 normalizedInformationContent "100" @default.
- NCIT_C61317 referenceCount "1" @default.
- NCIT_C61317 hasExactSynonym "DOXORUBICIN CITRATE" @default.
- NCIT_C61317 hasExactSynonym "Liposome-Encapsulated Doxorubicin Citrate" @default.
- NCIT_C61317 hasExactSynonym "Myocet" @default.
- NCIT_C61317 hasExactSynonym "liposome-encapsulated doxorubicin citrate" @default.
- NCIT_C61317 inSubset NCIT_C116977 @default.
- NCIT_C61317 inSubset NCIT_C116978 @default.
- NCIT_C61317 inSubset NCIT_C128784 @default.
- NCIT_C61317 inSubset NCIT_C157711 @default.
- NCIT_C61317 inSubset NCIT_C157712 @default.
- NCIT_C61317 inSubset NCIT_C176424 @default.
- NCIT_C61317 inSubset NCIT_C177537 @default.
- NCIT_C61317 inSubset NCIT_C63923 @default.
- NCIT_C61317 type Class @default.
- NCIT_C61317 isDefinedBy ncit.owl @default.
- NCIT_C61317 label "Liposome-Encapsulated Doxorubicin Citrate" @default.
- NCIT_C61317 subClassOf NCIT_C129824 @default.
- NCIT_C61317 subClassOf NCIT_C129825 @default.
- NCIT_C61317 subClassOf NCIT_C1594 @default.
- NCIT_C61317 subClassOf NCIT_C1748 @default.
- NCIT_C61317 subClassOf NCIT_C186664 @default.
- NCIT_C61317 subClassOf NCIT_C1908 @default.
- NCIT_C61317 subClassOf NCIT_C1909 @default.
- NCIT_C61317 subClassOf NCIT_C1968 @default.
- NCIT_C61317 subClassOf NCIT_C2115 @default.
- NCIT_C61317 subClassOf NCIT_C2161 @default.
- NCIT_C61317 subClassOf NCIT_C2189 @default.
- NCIT_C61317 subClassOf NCIT_C259 @default.
- NCIT_C61317 subClassOf NCIT_C274 @default.
- NCIT_C61317 subClassOf NCIT_C2842 @default.
- NCIT_C61317 subClassOf NCIT_C471 @default.
- NCIT_C61317 subClassOf NCIT_C61317 @default.
- NCIT_C61317 subClassOf NCIT_C67502 @default.